Fallout from Shkreli’s risky business model continues with concerns for another parasitic infection treatment . . . and his arrest
Something about efforts to fight parasites seems to bring out an urge in Martin Shkreli to fight back . . . . While the high-living pharmaceutical CEO faces a possible Club Fed staycation, pursuit of worldwide Chagas drug rights threatens treatment access A program intended to improve access and options to treatments for illnesses affecting […]